As of close of business last night, Lexaria Bioscience Corp’s stock clocked out at $4.48, up 32.54% from its previous closing price of $3.38. In other words, the price has increased by $+1.1000 from its previous closing price. On the day, 1340994 shares were traded.
Ratios:
To gain a deeper understanding of LEXX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.63 and its Current Ratio is at 21.63. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEXX now has a Market Capitalization of 40.77M and an Enterprise Value of 38.90M. For the stock, the TTM Price-to-Sale (P/S) ratio is 160.88 while its Price-to-Book (P/B) ratio in mrq is 12.34. Its current Enterprise Value per Revenue stands at 139.06 whereas that against EBITDA is -6.67.
Stock Price History:
Over the past 52 weeks, LEXX has reached a high of $3.61, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.8493, while the 200-Day Moving Average is calculated to be 1.2303.
Shares Statistics:
It appears that LEXX traded 248.39K shares on average per day over the past three months and 663.35k shares per day over the past ten days. A total of 12.21M shares are outstanding, with a floating share count of 10.37M. Insiders hold about 15.02% of the company’s shares, while institutions hold 9.83% stake in the company. Shares short for LEXX as of Feb 15, 2024 were 685.7k with a Short Ratio of 2.76, compared to 662.35k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.37% and a Short% of Float of 6.76%.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.1, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.13 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.47 and -$0.6 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.49, with 2 analysts recommending between -$0.48 and -$0.51.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for LEXX’s current fiscal year. The highest revenue estimate was $810k, while the lowest revenue estimate was $150k, resulting in an average revenue estimate of $480k. In the same quarter a year ago, actual revenue was $226k, up 112.40% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $970k in the next fiscal year. The high estimate is $970k and the low estimate is $970k. The average revenue growth estimate for next year is up 102.10% from the average revenue estimate for this year.
